Literature DB >> 25569802

Blockade of Multidrug Resistance-Associated Proteins Aggravates Acute Pancreatitis and Blunts Atrial Natriuretic Factor's Beneficial Effect in Rats: Role of MRP4 (ABCC4).

María Silvia Ventimiglia1, Ana Clara Najenson1, Juan Carlos Perazzo1, Alejandro Carozzo2, Marcelo S Vatta3, Carlos A Davio2, Liliana G Bianciotti1.   

Abstract

We previously reported that atrial natriuretic factor (ANF) stimulates secretin-evoked cAMP efflux through multidrug resistance-associated protein 4 (MRP4) in the exocrine pancreas. Here we sought to establish in vivo whether this mechanism was involved in acute pancreatitis onset in the rat. Rats pretreated with or without probenecid (MRPs general inhibitor) were infused with secretin alone or with ANF. A set of these animals were given repetitive cerulein injections to induce acute pancreatitis. Plasma amylase and intrapancreatic trypsin activities were measured and histological examination of the pancreas performed. Secretin alone activated trypsinogen but induced no pancreatic histological changes. Blockade by probenecid in secretin-treated rats increased trypsin and also induced vacuolization, a hallmark of acute pancreatitis. ANF prevented the secretin response but in the absence of probenecid. In rats with acute pancreatitis, pretreatment with secretin aggravated the disease, but ANF prevented secretin-induced changes. Blockade of MRPs in rats with acute pancreatitis induced trypsinogen activation and larger cytoplasmic vacuoles as well as larger areas of necrosis and edema that were aggravated by secretin but not prevented by ANF. The temporal resolution of intracellular cAMP levels seems critical in the onset of acute pancreatitis, since secretin-evoked cAMP in a context of MRP inhibition makes the pancreas prone to injury in normal rats and aggravates the onset of acute pancreatitis. Present findings support a protective role for ANF mediated by cAMP extrusion through MRP4 and further suggest that the regulation of MRP4 by ANF would be relevant to maintain pancreatic acinar cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569802      PMCID: PMC4461582          DOI: 10.2119/molmed.2014.00166

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  38 in total

1.  Atrial natriuretic factor negatively modulates secretin intracellular signaling in the exocrine pancreas.

Authors:  María E Sabbatini; Marcelo S Vatta; Carlos A Davio; Liliana G Bianciotti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-09-14       Impact factor: 4.052

2.  Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury.

Authors:  Albert M Song; Lakshmi Bhagat; Vijay P Singh; Gijs G D Van Acker; Michael L Steer; Ashok K Saluja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-11       Impact factor: 4.052

3.  Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

Authors:  C Niederau; L D Ferrell; J H Grendell
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

4.  Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma.

Authors:  Jörg König; Mark Hartel; Anne T Nies; Marc E Martignoni; Junchao Guo; Markus W Büchler; Helmut Friess; Dietrich Keppler
Journal:  Int J Cancer       Date:  2005-06-20       Impact factor: 7.396

5.  Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment.

Authors:  Rosely Oliveira Godinho; Valter Luiz Costa
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response.

Authors:  Z Ping Lin; Yong-Lian Zhu; Dennis R Johnson; Kevin P Rice; Timothy Nottoli; Bryan C Hains; James McGrath; Stephen G Waxman; Alan C Sartorelli
Journal:  Mol Pharmacol       Date:  2007-10-24       Impact factor: 4.436

Review 7.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

Authors:  Frans G M Russel; Jan B Koenderink; Rosalinde Masereeuw
Journal:  Trends Pharmacol Sci       Date:  2008-03-18       Impact factor: 14.819

8.  Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation.

Authors:  Yassine Sassi; Larissa Lipskaia; Grégoire Vandecasteele; Viacheslav O Nikolaev; Stéphane N Hatem; Fleur Cohen Aubart; Frans G Russel; Nathalie Mougenot; Cédric Vrignaud; Philippe Lechat; Anne-Marie Lompré; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.

Authors:  Sang-Wan Seo; Won-Seok Jung; Tai-Guang Piao; Seung-Heon Hong; Ki-Jung Yun; Rae-Kil Park; Min-Kyo Shin; Ho-Joon Song; Sung-Joo Park
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

10.  Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.

Authors:  Zuben E Sauna; Krishnamachary Nandigama; Suresh V Ambudkar
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

View more
  2 in total

1.  The exocrine pancreas is an extracardiac source of atrial natriuretic peptide.

Authors:  Ana C Najenson; Mariana Bianchi; Ana P Courreges; Myrian R Rodriguez; Víctor H Casco; Marcelo S Vatta; Liliana G Bianciotti
Journal:  Pflugers Arch       Date:  2019-01-08       Impact factor: 3.657

Review 2.  New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathway.

Authors:  Rosely O Godinho; Thiago Duarte; Enio S A Pacini
Journal:  Front Pharmacol       Date:  2015-03-24       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.